RT Journal Article
SR Electronic
T1 COVID-19 progression is potentially driven by T cell immunopathogenesis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.28.20083089
DO 10.1101/2020.04.28.20083089
A1 Anft, Moritz
A1 Paniskaki, Krystallenia
A1 Blazquez-Navarro, Arturo
A1 Doevelaar, Adrian
A1 Seibert, Felix S.
A1 Hoelzer, Bodo
A1 Skrzypczyk, Sarah
A1 Kohut, Eva
A1 Kurek, Julia
A1 Zapka, Jan
A1 Wehler, Patrizia
A1 Kaliszczyk, Sviatlana
A1 Bajda, Sharon
A1 Thieme, Constantin J.
A1 Roch, Toralf
A1 Konik, Margarethe Justine
A1 Brenner, Thorsten
A1 Tempfer, Clemens
A1 Watzl, Carsten
A1 Dolff, Sebastian
A1 Dittmer, Ulf
A1 Westhoff, Timm H.
A1 Witzke, Oliver
A1 Stervbo, Ulrik
A1 Babel, Nina
YR 2020
UL http://medrxiv.org/content/early/2020/05/19/2020.04.28.20083089.abstract
AB Background The role of cellular immunity in pathogenesis of COVID-19 is unclear and conflicting data points to insufficient or pathogenic immunity as drivers of COVID-19 progression. Here we aimed to delineate the phenotype and function of the immune system in patients with moderate, severe, and critical COVID-19.Methods In this prospective study, we included 53 patients with moderate (n=21), severe (n=18), and critical (n=14) COVID-19 manifestations. Using multiparametric flow cytometry we compared quantitative, phenotypic, and functional characteristics of circulating immune cells, SARS-CoV-2 antigen-reactive T-cells, and humoral immunity.Results Deep phenotypic profiling revealed a depletion of circulating bulk CD8+ T-cells, CD4+ and CD8+ T-cell subsets with activated memory/effector T-cells expressing CD57+, HLA-DR+, and the key activation and migration molecule CD11a++ in critical COVID-19. Importantly, survival from acute respiratory distress syndrome was accompanied by a recovery of the depleted CD11++ T-cell subsets including T-cells expressing CD28, CD57, HLA-DR activation/effector molecules. We further observed a stronger response of S-protein specific T-cells producing inflammatory cytokines in critical COVID-19 cases. This seemingly contradictory observation is in fact confirmation of the underlying immunopathogenesis in patients with critical COVID-19.Conclusion Our findings suggest a CD11a-based immune signature as a possible prognostic marker for disease development. Our data further reveal that increased rather than decreased SARS-CoV-2 specific T cell immunity is associated with adverse outcome in COVID-19. Tissue migration of activated effectors T-cells may constitute a crucial cornerstone in the immunopathogenesis of SARS-CoV-2 associated tissue injury.Trial registration This is a prospective observational study without a trial registration number.Funding This work was supported by grants from Mercator Foundation, the BMBF e:KID (01ZX1612A), and BMBF NoChro (FKZ 13GW0338B).25 Word summary Stronger S-protein reactivity and decreased frequency of activated memory/effector T-cells expressing CD11a++ suggests immunopathogenesis in critical COVID-19 mediated by tissue migration of activated effector T-cells.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from Mercator Foundation, the BMBF e:KID (01ZX1612A), and BMBF NoChro (FKZ 13GW0338B).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on request from the authors